Bronchial hyperresponsiveness (BHR) to methacholine and adenosine 5'-monophosphate (AMP) was studied in 15 allergic asthmatic patients before and 3 and 24 h after allergen challenge with hose dust mite (HDM). Subjects attended the clinic on 3 consecutive days. On the first day a control solution was inhaled, and methacholine or AMP challenge was performed 3 h later. The next day HDM was inhaled, and 3 and 24 h later methacholine or AMP challenge was performed again. There were no significant differences in FEV1 baseline values between any of the study days. PD20 HDM, percentage decrease in FEV1, and AUC for both the EAR and LAR were not significantly different in the methacholine and AMP studies. After HDM challenge, PC20 methacholine decre...
AbstractThe objective of this study was to determine differences in airway sensitivity to adenosine ...
Methacholine (MCh) and mannitol challenges are tests used to assess airway responsiveness. It has be...
BACKGROUND: Both bronchial responsiveness (BR) and peak expiratory flow (PEF) variability are increa...
Bronchial hyperresponsiveness (BHR) to methacholine and adenosine 5'-monophosphate (AMP) was studied...
Bronchial hyperresponsiveness (BHR) to methacholine and adenosine 5'-monophosphate (AMP) was studied...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Background In asthma patients, bronchial hyper‐responsiveness (BHR) to adenosine‐5′‐monophosphate (A...
Background In asthma patients, bronchial hyper‐responsiveness (BHR) to adenosine‐5′‐monophosphate (A...
Background In asthma patients, bronchial hyper-responsiveness (BHR) to adenosine-5'-monophosphate (A...
Background In asthma patients, bronchial hyper-responsiveness (BHR) to adenosine-5'-monophosphate (A...
ABSTRACT: Airway hyperresponsiveness (AHR) is a characteristic feature of asthma, but is also freque...
AbstractThe objective of this study was to determine differences in airway sensitivity to adenosine ...
Methacholine (MCh) and mannitol challenges are tests used to assess airway responsiveness. It has be...
BACKGROUND: Both bronchial responsiveness (BR) and peak expiratory flow (PEF) variability are increa...
Bronchial hyperresponsiveness (BHR) to methacholine and adenosine 5'-monophosphate (AMP) was studied...
Bronchial hyperresponsiveness (BHR) to methacholine and adenosine 5'-monophosphate (AMP) was studied...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Bronchial hyperresponsiveness (BHR) and inflammation are central hallmarks of asthma. Studies in pat...
Background In asthma patients, bronchial hyper‐responsiveness (BHR) to adenosine‐5′‐monophosphate (A...
Background In asthma patients, bronchial hyper‐responsiveness (BHR) to adenosine‐5′‐monophosphate (A...
Background In asthma patients, bronchial hyper-responsiveness (BHR) to adenosine-5'-monophosphate (A...
Background In asthma patients, bronchial hyper-responsiveness (BHR) to adenosine-5'-monophosphate (A...
ABSTRACT: Airway hyperresponsiveness (AHR) is a characteristic feature of asthma, but is also freque...
AbstractThe objective of this study was to determine differences in airway sensitivity to adenosine ...
Methacholine (MCh) and mannitol challenges are tests used to assess airway responsiveness. It has be...
BACKGROUND: Both bronchial responsiveness (BR) and peak expiratory flow (PEF) variability are increa...